Parietal white matter abnormalities in obsessive-compulsive disorder: A magnetic resonance spectroscopy study at 3-Tesla

Acta Psychiatrica Scandinavica

Volumn 114, Issue 2, 2006, Pages 101-108

  Kitamura, H ^a   Shioiri, T ^a   Kimura, T ^b   Ohkubo, M ^c   Nakada, T ^b   Someya, T ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Niigata University   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

Choline; Magnetic resonance spectroscopy; Myelin sheath; Obsessive compulsive disorder; Parietal lobe; Phospholipids

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; N ACETYLASPARTIC ACID; PHOSPHOLIPID;

ADOLESCENT; ADULT; ARTICLE; BASAL GANGLION; BRAIN DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; FRONTAL CORTEX; GLIA CELL; HUMAN; HYPOTHESIS; MALE; MYELINATED NERVE; NERVE CELL NETWORK; NERVE FIBER; NEUROCHEMISTRY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; PARIETAL LOBE; PRIORITY JOURNAL; THALAMUS; WHITE MATTER;

ADOLESCENT; ADULT; ASPARTIC ACID; CHOLINE; CREATINE; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NERVE NET; OBSESSIVE-COMPULSIVE DISORDER; PARIETAL LOBE;

EID: 33745824655     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2006.00858.x     Document Type: Article

References (43)

1. SWEDO SE, SCHAPIRO MB, GRADY CL et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry 1989;46:518-523.
2. RAUCH SL, JENIKE MA, ALPERT NM et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994;51:62-70.
3. BREITER HC, RAUCH SL, KWONG KK et al. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry 1996;53:595-606.
4. ADLER CM, MCDONOUGH-RYAN P, SAX KW, HOLLAND SK, ARNDT S, STRAKOWSKI SM. fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive-compulsive disorder. J Psychiatr Res 2000;34:317-324.
5. OGAI M, IYO M, MORI N, TAKEI N. A right orbitofrontal region and OCD symptoms: a case report. Acta Psychiatr Scand 2005;111:74-76.
6. WHITESIDE SP, PORT JD, ABRAMOWITZ JS. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res 2004;132:69-79.
7. VAN DEN HEUVEL OA, VELTMAN DJ, GROENEWEGEN HJ et al. Amygdala activity in obsessive-compulsive disorder with contamination fear: a study with oxygen-15 water positron emission tomography. Psychiatry Res 2004;132:225-237.
8. RAPOPORT JL, WISE SP. Obsessive-compulsive disorder: evidence for basal ganglia dysfunction. Psychopharmacol Bull 1988;24:380-384.
9. BREITER HC, FILIPEK PA, KENNEDY DN et al. Retrocallosal white matter abnormalities in patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1994;51:663-664.
10. JENIKE MA, BREITER HC, BAER L et al. Cerebral structural abnormalities in obsessive-compulsive disorder. A quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry 1996;53:625-632.
11. RIFFKIN J, YUCEL M, MARUFF P et al. A manual and automated MRI study of anterior cingulate and orbito-frontal cortices, and caudate nucleus in obsessive-compulsive disorder: comparison with healthy controls and patients with schizophrenia. Psychiatry Res 2005;138:99-113.
12. ROSENBERG DR, KESHAVAN MS, DICK EL, BAGWELL WW, MACMASTER FP, BIRMAHER B. Corpus callosal morphology in treatment-naive pediatric obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 1997;21:1269-1283.
13. SZESZKO PR, MACMILLAN S, MCMENIMAN M et al. Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. Am J Psychiatry 2004;161:1049-1056.
14. SZESZKO PR, ARDEKANI BA, ASHTARI M et al. White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study. Arch Gen Psychiatry 2005;62:782-790.
15. VALENTE Jr AA, MIGUEL EC, CASTRO CC et al. Regional gray matter abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study. Biol Psychiatry 2005;58:479-487.
16. BARTHA R, STEIN MB, WILLIAMSON PC et al. A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. Am J Psychiatry 1998;155:1584-1591.
17. EBERT D, SPECK O, KONIG A, BERGER M, HENNIG J, HOHAGEN F. 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiatry Res 1997;74:173-176.
18. FITZGERALD KD, MOORE GJ, PAULSON LA, STEWART CM, ROSENBERG DR. Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder. Biol Psychiatry 2000;47:174-182.
19. OHARA K, ISODA H, SUZUKI Y et al. Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive-compulsive disorder. Psychiatry Res 1999;92:83-91.
20. ROSENBERG DR, AMPONSAH A, SULLIVAN A, MACMILLAN S, MOORE GJ. Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging. J Child Neurol 2001;16:636-641.
21. SMITH EA, RUSSELL A, LORCH E et al. Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study. Biol Psychiatry 2003;54:1399-1405.
22. FREEMAN JJ, JENDEN DJ. The source of choline for acetylcholine synthesis in brain. Life Sci 1976;19:949-962.
23. MILLER BL, CHANG L, BOOTH R et al. In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci 1996;58:1929-1935.
24. KIM DS, GARWOOD M. High-field magnetic resonance techniques for brain research. Curr Opin Neurobiol 2003;13:612-619.
25. NAKADA T. Clinical experience on 3.0 T systems in Niigata, 1996 to 2002. Invest Radiol 2003;38:377-384.
26. OHKUBO M, KIMURA T, MATSUZAWA H, MATSUDA T, KWEE IL, NAKADA T. Evaluation of efficacy of an automated single-voxel proton MRS algorithm on a 3T system. Magn Reson Med Sci 2002;1:121-124.
27. WEBB PG, SAILASUTA N, KOHLER SJ, RAIDY T, MOATS RA, HURD RE. Automated single-voxel proton MRS: technical development and multisite verification. Magn Reson Med 1994;31:365-373.
28. American Psychiatric Association. Diagnostic and statistical manual of metal disorders, 4th edn. Washington, DC, USA: American Psychiatric Association, 1994.
29. SHEEHAN DV, LECRUBIER Y, SHEEHAN KH et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl. 20):22-33.
30. GOODMAN WK, PRICE LH, RASMUSSEN SA et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-1011.
31. GOODMAN WK, PRICE LH, RASMUSSEN SA et al. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry 1989;46:1012-1016.
32. ZUNG WW. A self-rating depression scale. Arch Gen Psychiatry 1965;12:63-70.
33. ZUNG WW. A rating instrument for anxiety disorders. Psychosomatics 1971;12:371-379.
34. OLDFIELD RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971;9:97-113.
35. SCHACHTER SC, RANSIL BJ, GESCHWIND N. Associations of handedness with hair color and learning disabilities. Neuropsychologia 1987;25:269-276
36. TALAIRACH J, TORNOUX P. Co-planar stereotaxic atlas of the human brain. New York: Thieme Medical Publishers, 1988.
37. KREIS R, FARROW N, ROSS BD. Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed 1991;4:109-116.
38. VAN DER KNAAP MS, VAN DER GROND J, VAN RIJEN PC, FABER JA, VALK J, WILLEMSE K. Age dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology 1990;176:509-515.
39. KREIS R, ERNST T, ROSS BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30:424-437.
40. KADOTA T, HORINOUCHI T, KURODA C. Development and aging of the cerebrum: assessment with proton MR spectroscopy. AJNR Am J Neuroradiol 2001;22:128-135.
41. BOLDRINI M, DEL PACE L, PLACIDI GP et al. Selective cognitive deficits in obsessive-compulsive disorder compared to panic disorder with agoraphobia. Acta Psychiatr Scand 2005;111:150-158.
42. PURCELL R, MARUFF P, KYRIOS M, PANTELIS C. Neuropsychological deficits in obsessive-compulsive disorder: a comparison with unipolar depression, panic disorder, and normal controls. Arch Gen Psychiatry 1998;55:415-423.
43. MASSANA G, GASTO C, JUNQUE C et al. Reduced levels of creatine in the right medial temporal lobe region of panic disorder patients detected with (1) H magnetic resonance spectroscopy. Neuroimage 2002;16:836-842.